Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
5949097 | Atherosclerosis | 2012 | 7 Pages |
Abstract
It suggests that cilostazol may have beneficial effects in preventing the progression of carotid atherosclerosis and improving pro-atherogenic lipid profile, especially in patients with T2DM. Whether the anti-atherosclerotic effect of cilostazol is independent of improving pro-atherogenic dyslipidemia is worth further investigation.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Deng-feng Geng, Jing Deng, Dong-mei Jin, Wei Wu, Jing-feng Wang,